content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001754937</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001737287</issuerCik>
        <issuerName>Allogene Therapeutics, Inc.</issuerName>
        <secFileNumber>001-38693</secFileNumber>
        <issuerAddress>
          <com:street1>210 EAST GRAND AVENUE</com:street1>
          <com:city>SOUTH SAN FRANCISCO</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94080</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>(650) 457-2700</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>MOORE ALISON</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Officer</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>Merrill Lynch</name>
          <address>
            <com:street1>225 Liberty St</com:street1>
            <com:street2>Floor 37</com:street2>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10281</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>531854</noOfUnitsSold>
        <aggregateMarketValue>3052841.96</aggregateMarketValue>
        <noOfUnitsOutstanding>145841620</noOfUnitsOutstanding>
        <approxSaleDate>06/12/2023</approxSaleDate>
        <securitiesExchangeName>NASDAQ</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <acquiredDate>06/12/2023</acquiredDate>
        <natureOfAcquisitionTransaction>Exercise of employee stock options</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Allogene Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>437080</amountOfSecuritiesAcquired>
        <paymentDate>06/12/2023</paymentDate>
        <natureOfPayment>Broker assisted cashless exercise</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <acquiredDate>06/28/2019</acquiredDate>
        <natureOfAcquisitionTransaction>Exercise of employee stock options</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Allogene Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>498</amountOfSecuritiesAcquired>
        <paymentDate>06/28/2019</paymentDate>
        <natureOfPayment>Cash</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <acquiredDate>03/13/2020</acquiredDate>
        <natureOfAcquisitionTransaction>Vesting of restricted stock unit award</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Allogene Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>5512</amountOfSecuritiesAcquired>
        <paymentDate>03/13/2020</paymentDate>
        <natureOfPayment>Granted as part of issuer equity compensation plan</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <acquiredDate>08/13/2020</acquiredDate>
        <natureOfAcquisitionTransaction>Exercise of employee stock options</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Allogene Therapeutics, Inc</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>32451</amountOfSecuritiesAcquired>
        <paymentDate>08/13/2020</paymentDate>
        <natureOfPayment>Cash</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <acquiredDate>03/13/2021</acquiredDate>
        <natureOfAcquisitionTransaction>Vesting of restricted stock unit award</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Allogene Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>10799</amountOfSecuritiesAcquired>
        <paymentDate>03/13/2021</paymentDate>
        <natureOfPayment>Granted as part of issuer equity compensation plan</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <acquiredDate>03/13/2022</acquiredDate>
        <natureOfAcquisitionTransaction>Vesting of restricted stock unit award</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Allogene Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>23178</amountOfSecuritiesAcquired>
        <paymentDate>03/13/2022</paymentDate>
        <natureOfPayment>Granted as part of issuer equity compensation plan</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <acquiredDate>03/13/2023</acquiredDate>
        <natureOfAcquisitionTransaction>Vesting of restricted stock unit award</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Allogene Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>14829</amountOfSecuritiesAcquired>
        <paymentDate>03/13/2023</paymentDate>
        <natureOfPayment>Granted as part of issuer equity compensation plan</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <acquiredDate>03/15/2023</acquiredDate>
        <natureOfAcquisitionTransaction>Employee stock purchase plan</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Allogene Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>2000</amountOfSecuritiesAcquired>
        <paymentDate>03/15/2023</paymentDate>
        <natureOfPayment>Cash</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <acquiredDate>03/15/2022</acquiredDate>
        <natureOfAcquisitionTransaction>Employee stock purchase plan</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Allogene Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>1688</amountOfSecuritiesAcquired>
        <paymentDate>03/15/2022</paymentDate>
        <natureOfPayment>Cash</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <acquiredDate>09/15/2021</acquiredDate>
        <natureOfAcquisitionTransaction>Employee stock purchase plan</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Allogene Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>558</amountOfSecuritiesAcquired>
        <paymentDate>09/15/2021</paymentDate>
        <natureOfPayment>Cash</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <acquiredDate>03/15/2021</acquiredDate>
        <natureOfAcquisitionTransaction>Employee stock purchase plan</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Allogene Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>368</amountOfSecuritiesAcquired>
        <paymentDate>03/15/2021</paymentDate>
        <natureOfPayment>Cash</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <acquiredDate>09/15/2020</acquiredDate>
        <natureOfAcquisitionTransaction>Employee stock purchase plan</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Allogene Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>718</amountOfSecuritiesAcquired>
        <paymentDate>09/15/2020</paymentDate>
        <natureOfPayment>Cash</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <acquiredDate>03/13/2020</acquiredDate>
        <natureOfAcquisitionTransaction>Employee stock purchase plan</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Allogene Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>704</amountOfSecuritiesAcquired>
        <paymentDate>03/13/2020</paymentDate>
        <natureOfPayment>Cash</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <acquiredDate>09/13/2019</acquiredDate>
        <natureOfAcquisitionTransaction>Employee stock purchase plan</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Allogene Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>694</amountOfSecuritiesAcquired>
        <paymentDate>09/13/2019</paymentDate>
        <natureOfPayment>Cash</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <acquiredDate>03/15/2019</acquiredDate>
        <natureOfAcquisitionTransaction>Employee stock purchase plan</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Allogene Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>507</amountOfSecuritiesAcquired>
        <paymentDate>03/15/2019</paymentDate>
        <natureOfPayment>Cash</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Alison Moore</name>
          <address>
            <com:street1>210 EAST GRAND AVENUE</com:street1>
            <com:city>SOUTH SAN FRANCISCO</com:city>
            <com:stateOrCountry>CA</com:stateOrCountry>
            <com:zipCode>94080</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <saleDate>03/14/2023</saleDate>
        <amountOfSecuritiesSold>8351</amountOfSecuritiesSold>
        <grossProceeds>45989.75</grossProceeds>
      </securitiesSoldInPast3Months>
      <noticeSignature>
        <noticeDate>06/12/2023</noticeDate>
        <signature>Alison Moore</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 11515}]
text: 144
  0001754937
  XXXXXXXX
  LIVE
  0001737287
  Allogene Therapeutics, Inc.
  001-38693
  210 EAST GRAND AVENUE
  SOUTH SAN FRANCISCO
  CA
  94080
  (650) 457-2700
  MOORE ALISON
  Officer
  Common Stock
  Merrill Lynch
  225 Liberty St
  Floor 37
  New York
  NY
  10281
  531854
  3052841.96
  145841620
  06/12/2023
  NASDAQ
  Common Stock
  06/12/2023
  Exercise of employee stock options
  Allogene Therapeutics, Inc.
  N
  437080
  06/12/2023
  Broker assisted cashless exercise
  Common Stock
  06/28/2019
  Exercise of employee stock options
  Allogene Therapeutics, Inc.
  N
  498
  06/28/2019
  Cash
  Common Stock
  03/13/2020
  Vesting of restricted stock unit award
  Allogene Therapeutics, Inc.
  N
  5512
  03/13/2020
  Granted as part of issuer equity compensation plan
  Common Stock
  08/13/2020
  Exercise of employee stock options
  Allogene Therapeutics, Inc
  N
  32451
  08/13/2020
  Cash
  Common Stock
  03/13/2021
  Vesting of restricted stock unit award
  Allogene Therapeutics, Inc.
  N
  10799
  03/13/2021
  Granted as part of issuer equity compensation plan
  Common Stock
  03/13/2022
  Vesting of restricted stock unit award
  Allogene Therapeutics, Inc.
  N
  23178
  03/13/2022
  Granted as part of issuer equity compensation plan
  Common Stock
  03/13/2023
  Vesting of restricted stock unit award
  Allogene Therapeutics, Inc.
  N
  14829
  03/13/2023
  Granted as part of issuer equity compensation plan
  Common Stock
  03/15/2023
  Employee stock purchase plan
  Allogene Therapeutics, Inc.
  N
  2000
  03/15/2023
  Cash
  Common Stock
  03/15/2022
  Employee stock purchase plan
  Allogene Therapeutics, Inc.
  N
  1688
  03/15/2022
  Cash
  Common Stock
  09/15/2021
  Employee stock purchase plan
  Allogene Therapeutics, Inc.
  N
  558
  09/15/2021
  Cash
  Common Stock
  03/15/2021
  Employee stock purchase plan
  Allogene Therapeutics, Inc.
  N
  368
  03/15/2021
  Cash
  Common Stock
  09/15/2020
  Employee stock purchase plan
  Allogene Therapeutics, Inc.
  N
  718
  09/15/2020
  Cash
  Common Stock
  03/13/2020
  Employee stock purchase plan
  Allogene Therapeutics, Inc.
  N
  704
  03/13/2020
  Cash
  Common Stock
  09/13/2019
  Employee stock purchase plan
  Allogene Therapeutics, Inc.
  N
  694
  09/13/2019
  Cash
  Common Stock
  03/15/2019
  Employee stock purchase plan
  Allogene Therapeutics, Inc.
  N
  507
  03/15/2019
  Cash
  N
  Alison Moore
  210 EAST GRAND AVENUE
  SOUTH SAN FRANCISCO
  CA
  94080
  Common Stock
  03/14/2023
  8351
  45989.75
  06/12/2023
  Alison Moore